C. Wiggins

A phase I trial of recombinant tumor necrosis factor (rTNF) administered by continuous intravenous infusion in patients with disseminated malignancy

E. Hersh, P. Scuderi, J. E. Schwartz, 1989, Biotherapy.

Clinical Regression and Remission of Primary Refractory Angiocentric Lymphoma Following Autologous Tumour Peptide Antigen-charged Dendritic Cells After High-dose Chemotherapy and Autologous Stem Cell Rescue.

C. Wiggins, M. Williams, A. Newland, 1998, Hematology.

Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma.

T. Lister, R. Gupta, A. Rohatiner, 2000, The hematology journal : the official journal of the European Haematology Association.

Preservation and stability of cell therapy products: recommendations from an expert workshop.

A. Dickson, K. Coopman, C. Connon, 2017, Regenerative medicine.

Cryopreservation and Banking of Haematopoietic Progenitor Cells

C. Wiggins, 2021, Essentials of Tissue and Cells Banking.

Phase I study of adozelesin (U-73,975) in patients with solid tumors.

D. Alberts, C. Wiggins, G. Elfring, 1994, Anti-cancer drugs.

Preservation and stability of cell therapy products: recommendations from an expert workshop.

A. Dickson, K. Coopman, C. Connon, 2017, Regenerative medicine.